Products
Title: How is the on-target capture rate of NEX-t Panel v1.0? Whether two rounds of hybridization are required to increase the on-target rate?
  • The on-target rate of pathogens are significantly influenced by the amount of pathogens within the samples. As shown in Figure, under the same host background, as the microbial reference material is gradually diluted, the amount of data decreases proportionally, along with a decrease in on-target rate.


  • Although multiple capture rounds can substantially improve on-target rate, this strategy comes with the risk of information loss (dropout). Especially when the amount of pathogen is low, the on-target rate is low and is more l sensitive to dropout. Therefore, careful consideration of the pros and cons is needed when contemplating multiple capture rounds. Additionally, from another perspective, when the pathogen genome copy numbers in the sample are in the single digits, increasing on-target rate merely involves repetitive sequencing of these few copies, yielding limited additional useful information.fig4Note: Simulated microbial community samples of 0.001% - 1% MSA-1003 were created by diluting a mixture of 20 strains of genomic material (ATCC, MSA-1003) using the human genomic DNA standard (Promega, G1471) at various ratios. Library preparation was performed using 50 ng input with the NadPrep EZ DNA Library Preparation Kit v2, followed by hybrid capture (2-hour hybridization) using NEX-t Panel v1.0 with NadPrep ES Hybrid Capture Reagents. Sequencing platform: Illumina Novaseq6000, PE150. The BWA was used for alignment of raw reads to the reference genome composed of the hg19 human genome and 20 microbial genome reference sequences, and reads distribution was analyzed.


Title: How NEX-t Panel v1.0 shortens TAT and improves the convenience of hybrid capture operation? NEX-t Panel v1.0 is recommended for use  in conjunction with NadPrep ES Hybrid Capture Reagents, which significantly shorten the hybridization time while simplifying the experimental steps.Hybrid capture sequencing is more robust and has a lower failure rate than multiplex amplicon sequencing.
Title: What are the advantages of NEX-t Panel v1.0 at the probe design level, and how to balance capture performance and economic cost?
  • In general, achieving complete probe coverage of pathogen microbiome genomes is impractical. On one hand, designing probes for a single bacterial species can result in hundreds of thousands of probes when considering sequence polymorphism beyond reference genomes.  On the other hand, to prevent off-target effects when there is similarity between pathogenic and host sequences, certain regions must be excluded. Therefore, NEX-t Panel v1.0 emphasizes designing the fewest probes to enable the broadest range of pathogen analysis, resulting in a significantly streamlined panel size compared to tNGS schemes with millions of probes in hybrid capture.
  • The number of probes can be roughly equivalent to the number of amplicons in multiplex PCR. However, due to the higher tolerance of probes and the ability to capture sequences flanking the probe, a certain number of probes can provide more diverse information compared to a similar number of multiplex amplicons.
  • Compared to multiplex PCR, expanding a hybrid capture panel is simpler as it only requires adding probes. Therefore, NEX-t Panel v1.0 can be conveniently customized and upgraded through combination.
图片1
Title: In the demo data, the sequencing mode is PE150. If the SE50/75 sequencing mode is used, will it affect the result interpretation? Is it necessary to increase the sequencing data volume further? In pathogen detection, SE sequencing mode is more time-efficient and is therefore more commonly used than PE mode. Regardless of the sequencing mode chosen, as long as a sufficient number of reads is detected, it can be used for pathogen analysis and will not affect the final result interpretation. When using SE50/75 sequencing mode, there is no need to increase the sequencing data volume. The current demo data, actually in PE150 mode, can be effectively analyzed as if it were SE50 or SE100 data, ensuring reliable pathogen detection.
Title: Is the minimum acceptable data volume for each sample in single-library and/or dual-library detecting 1 million reads, and in mixed samples, is it sufficient for the data volume to be greater than this threshold for reporting? The actual amount of data obtained from sequencing depends on the content of pathogenic microorganisms in clinical specimens. Whether a report is generated is based on the number of supporting reads detected for the pathogen, and is not related to the total amount of data obtained from sequencing. If a predicted credible pathogenic microorganism is shown as undetected in the report, even with sufficient data, it may be advisable to increase the data volume for further bioinformatics analysis or perform verification using PCR. Conversely, if the sequencing data volume is very low but enough supporting data is detected for a pathogen microorganism, a report may still be generated.
Title: How should one choose a sequencer and sequencing mode for tNGS pathogen microorganism detection? To obtain rapid identification results of pathogenic microorganisms in clinical specimens, it is recommended to use BGI's DNBSEQ-G99 (SE100) / DNBSEQ-E25 (SE100), which allows for a minimum run time of 5 hours, or Illumina MiniSeq/MiSeq (SE100), also with a minimum run time of 5 hours.
Title: What specific processes are involved in tNGS pathogen microorganism detection, and how long does the entire process take? The complete tNGS pathogen microorganism detection process includes nucleic acid extraction (1.5 hr), RNA/DNA library preparation(~5.5/2.5 hr), hybrid capture (~4 hr), NGS sequencing (~5 hr), bioinformatics analysis, and automated report interpretation (~0.5 hr), with a total estimated time of approximately 13.5 to 16.5 hours.
Title: How many genera and species of pathogenic microorganisms are specifically covered by NEX-t Panel v1.0? NEX-t Panel v1.0 targets a series of characteristic sequences selected from the genomes of hundreds of pathogens including viruses, bacteria, fungi and parasites. It covers a rich range of content including 16S/ITS, housekeeping genes, drug-resistant related genes, and more. A single test encompasses over 450 genera and comprehensively covers 7000+ species of pathogenic microorganisms, meeting more than 99% of clinical pathogen detection needs (see attached species list for details).
Title: What are the requirements for nucleic acid extraction in pathogen-targeted next-generation sequencing (tNGS) detection?

The quality of nucleic acid extraction is crucial in determining the success of high-throughput sequencing tests. Different laboratories should establish comprehensive nucleic acid extraction procedures. Firstly, the selected nucleic acid extraction reagents should be validated to ensure the efficiency and integrity of nucleic acid extraction. Quantitative measurements should be performed on each extracted nucleic acid sample to ensure that they meet the requirements for subsequent experiments. Simultaneously, standards for qualified nucleic acid samples should be established.

Nucleic Acid Quality Verification:

(1) High-quality DNA should have an A260/A280 ratio between 1.7 ~1.9, and A260/A230 > 2. DNA quality can be verified by 1% agarose gel electrophoresis (no impurities, no smearing, and no protein contamination in the background).

(2) DNA integrity should be assessed using techniques such as Agilent 2100 Bioanalyzer. If the majority of fragments are below 200 nt (except for plasma cell-free DNA, which may be 140 nt), it indicates severe DNA degradation and requires re-extraction.

(3) High-quality RNA should have an A260/A280 ratio between 1.8 ~ 2.0, with an A260/A230 ratio greater than 2.

(4) Small amounts of nucleic acid should be quantified using the Qubit fluorescence dye method.

In summary, during clinical sample collection, it is essential to ensure an adequate amount of the sample for nucleic acid extraction to obtain higher abundance nucleic acid samples. The higher the abundance of pathogenic microorganisms in the libraries prepared for tNGS, the lower the limit of detection (LOD) in tNGS detecting. This allows for efficient detection of low-load pathogenic microorganisms.

This information is primarily sourced from "Expert Consensus on the Application of High-Throughput Sequencing Technology in the Diagnosis of Mycobacterial Diseases" and "Expert Consensus on Standardizing Clinical Applications of High-Throughput Metagenomic Sequencing for Pathogen Detection."

Title: What specific requirements are needed for pathogen-targeted next-generation sequencing (tNGS) detection for different types of clinical specimens?

The quality of clinical specimens directly affects the detection results. The extent to which different specimen types are influenced by colonizing microorganisms varies, leading to differences in the reliability of tNGS detection results.

The collection requirements for different types of clinical specimens

Type

Volume

DNA Sample Requirements

RNA Sample Requirements

Collection Tube

Storage

Transportation

Collection Tube

Storage

Transportation

Blood

10 mL

Vacutainer with Preservation Solution

Store at 4°C for one week

Cold Pack Transportation

Vacutainer with Preservation Solution

Store at 4°C for one week

Cold Pack Transportation

Bronchoalveolar Lavage Fluid

10 mL

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Sputum

3 mL

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Cerebrospinal Fluid

2 mL

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Pleural Fluid

25mL

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Ascitic Fluid

25 mL

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Bone Marrow

0.5 mL

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Other Body Fluids

10 mL

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Stool

Size of soybean grains

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Sterile Spiral Tube

Long-term storage at -80°C

Dry Ice

Swab

3 units

Preservative Sample Tube

Long-term storage at -80°C

Dry Ice

Preservative Sample Tube

Long-term storage at -80°C

Dry Ice

Fresh Tissue

size of rice grains

Tissue Sampling Tube

Long-term storage at -80°C

Dry Ice

Tissue Sampling Tube

Long-term storage at -80°C

Dry Ice

The primary information is sourced from the Expert Consensus on the Application of High-Throughput Sequencing Technology in the Diagnosis of Mycobacterial Diseases.